[HTML] frontiersin.org

[HTML][HTML] Dissecting tumor antigens and immune subtypes of glioma to develop mRNA vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou, F Tang… - Frontiers in …, 2021 - frontiersin.org
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …
被引用次数：41 相关文章
[HTML] nih.gov

[HTML][HTML] Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …
[PDF] researchgate.net

[PDF][PDF] Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Front. Immunol. 12 …, 2021 - researchgate.net
Background: Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …
[PDF] kobv.de

[PDF][PDF] Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Frontiers in …, 2021 - opus4.kobv.de
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Frontiers in …, 2021 - europepmc.org
Background Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …
[PDF] kobv.de

[PDF][PDF] Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine

H Zhong, S Liu, F Cao, Y Zhao, J Zhou… - Front. Immunol. 12 …, 2021 - opus4.kobv.de
Background: Nowadays, researchers are leveraging the mRNA-based vaccine technology
used to develop personalized immunotherapy for cancer. However, its application against …